"Pharmacovigilance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The detection of long and short term side effects of conventional and traditional medicines through research, data mining, monitoring, and evaluation of healthcare information obtained from healthcare providers and patients.
| Descriptor ID |
D060735
|
| MeSH Number(s) |
E05.337.800.600 N06.850.505.636
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pharmacovigilance".
Below are MeSH descriptors whose meaning is more specific than "Pharmacovigilance".
This graph shows the total number of publications written about "Pharmacovigilance" by people in this website by year, and whether "Pharmacovigilance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pharmacovigilance" by people in Profiles.
-
Cutaneous T-cell lymphoma after chronic exposure to hydrochlorothiazide: pharmacovigilance analysis from the RADAR (Research on Adverse Drug events And Reports) Program. J Eur Acad Dermatol Venereol. 2021 Feb; 35(2):e106-e108.
-
21st century pharmacovigilance: efforts, roles, and responsibilities. Lancet Oncol. 2016 Nov; 17(11):e486-e492.
-
The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits. Am J Gastroenterol. 2013 Jun; 108(6):866-72.
-
Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System. J Am Acad Dermatol. 2013 Sep; 69(3):393-8.
-
Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants. Expert Opin Drug Saf. 2012 Mar; 11(2):177-83.
-
Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. Am J Psychiatry. 2012 Feb; 169(2):167-77.